Form 4: Peter Arduini Reports Acquisition of Bristol-Myers Squibb Deferred Share Units

Director Peter Arduini reports the acquisition of deferred share units in Bristol-Myers Squibb, convertible to common stock upon future settlement.

Summary

• Peter J. Arduini, a director of Bristol-Myers Squibb, filed a Form 4 indicating changes in beneficial ownership.
• On February 1, 2025, Arduini acquired 3,562.341 deferred share units, each convertible into one share of common stock upon settlement.
• The price per share for the deferred share units is $58.95.
• Following the transaction, Arduini beneficially owns 60,937.918 deferred share units, including deferred compensation and reinvested dividends.
• The deferred share units become settleable when Arduini ceases to be a director or at a previously specified future date.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, indicating a neutral sentiment. It reflects routine transactions related to executive compensation.

Future Outlook

The deferred share units will be converted into common stock upon settlement, either when the reporting person ceases to be a director or at a future date previously specified.

Industry Context

This filing is a routine disclosure of a director's acquisition of deferred share units, a common form of executive compensation in publicly traded companies.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, as it involves deferred compensation for a director.
• It provides transparency regarding the director's holdings in the company.

Next Steps

• The deferred share units will be converted into common stock upon settlement at a future date.

Key Dates

Keywords

Form 4, beneficial ownership, deferred share units, Bristol-Myers Squibb, Arduini, director